<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Phase I Trial of Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis</title>
	<atom:link href="http://www.unitedspinal.org/publications/msqr/2005/07/11/phase-i-trial-of-immunotherapy-with-bht-3009-alone-or-combined-with-atorvastatin-in-patients-with-multiple-sclerosis/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.unitedspinal.org/publications/msqr/2005/07/11/phase-i-trial-of-immunotherapy-with-bht-3009-alone-or-combined-with-atorvastatin-in-patients-with-multiple-sclerosis/</link>
	<description>A publication of United Spinal Association and the CMSC/North American Research Committee on MS</description>
	<pubDate>Tue, 06 Jan 2009 05:52:30 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.5.1</generator>
	</channel>
</rss>
